20020 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Devices and methods to treat and prevent diverticulitis
#6002Preventing non-target embolization
#6003Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption
#6004URICASE SEQUENCES AND METHODS OF TREATMENT
#6005BLOOD-BRAIN BARRIER TRANSMIGRATING THERAPEUTIC COMPOUNDS AND USES THEREOF
#6006Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta
#6007Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof
#6008CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF BACKGROUND
#6009Main group metal complex and its preparation method and use
#6010Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
#6011Compositions and methods for the diagnosis, treatment and prevention of neoplastic and neurological disorders
#6012SUBSTITUTED TRIAZOLE DERIVATIVES AND USES THEREOF
#6013Emulsion for ultrasound ablation surgery
#6014METHODS OF TREATING NAUSEA UTILIZING SEMI-SOLID DELIVERY VEHICLE COMPOSITIONS COMPRISING GRANISETRON
#6015USES OF TREHALOSE IN CELL SUSPENSIONS
#6016VEGF Antagonist Formulations
#6017METHODS OF TREATING CANCER USING COMBINATION THERAPY
#6018ALUMINUM BASED ADJUVANTS FOR TOLEROGENIC VACCINATION
#6019Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
#6020PIC1 inhibition of myeloperoxidase oxidative activity in an animal model
#6021GLP-1 compositions and uses thereof
#6022Use of GHRP-6 as late cardioprotective and cardiac restoration medicament
#6023Gene editing to improve joint function
#6024METHOD FOR CARTILAGE REPAIR AND PRE-OSTEOARTHRITIS TREATMENT
#6025IMMUNE EFFECTOR CELLS AND MOLECULAR ADAPTORS WITH AN ANTIGEN CYTOKINE COMPLEX FOR EFFECTIVE IMMUNOTHERAPY
#6026Vitamin supplement compositions for injection
#6027SYNERGIC PHARMACEUTICAL COMBINATION OF A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 AND AN ANTHRAQUINONE DERIVATIVE
#6028COMPOSITION FOR THE PREVENTION OR THE TREATMENT OF VISUAL IMPAIRMENTS COMPRISING URSODEOXYCHOLIC ACID
#6029FORMULATIONS OF DEOXYCHOLIC ACID AND SALTS THEREOF
#6030Preparation of microparticulate methylprednisolone acetate suspension
#6031CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING INFLAMMATORY BOWEL DISEASE
#6032LEVOTHYROXINE LIQUID FORMULATIONS
#6033Nanoparticles containing a taxane and their use
#6034Preparation of Microparticulate Triamcinolone Acetonide Injectable Suspension
#6035N-acetylcysteine compositions and methods
#6036Ready to use liquid formulation
#6037INJECTABLE FORMULATIONS FOR TREATING CANCER
#6038Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
#6039VECTORS AND METHODS OF USE
#6040High concentration antibody-containing liquid formulation
#6041DRUG DELIVERY COMPOSITIONS AND USES THEREOF
#6042NOVEL ANTIGEN BINDING DIMER-COMPLEXES, METHODS OF MAKING/AVOIDING AND USES THEREOF
#6043BIO-IMAGING PROBES AND METHODS FOR NON-INVASIVE DETECTION OF HUMAN UTERINE SARCOMAS
#6044MIRI26-5P FOR TREATING MOTOR NEURON DISEASES
#6045SESAME OIL BASED INJECTION FORMULATIONS
#6046Naltrexone Long Acting Formulations and Methods of Use
#6047Injectable slurries and methods of manufacturing and using the same
#6048Human alpha-galactosidase variants
#6049Compositions and methods for treating Pompe disease
#6050Use of ultrarapid acting insulin
#6051COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN AN AMYLIN RECEPTOR AGONIST OR AN AMYLIN ANALOG, AT LEAST ONE IONIC SPECIES AND AN AMPHOIPHILIC COMPOUNDS CONTAINING HYDRIPHOBIC RADICALS
#6052DENTAL PULP STEM CELLS AND USES THEREOF
#6053Methods for the treatment of autism spectrum disorders
#6054COMPOSITION COMPRISING A THERAPEUTIC AGENT AND A RESPIRATORY STIMULANT AND METHODS FOR THE USE THEREOF
#6055THERAPEUTIC COMBINATIONS OF DRUGS FOR TREATING, PREVENTING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#6056Therapeutical composition containing apomorphine as active ingredient
#6057DIFFUSION ENHANCING COMPOUNDS AND THEIR USE WITH THROMBECTOMY AND EMBOLECTOMY AND OTHER VASCULAR DISEASE PROCEDURES
#6058METABOLITES FOR TREATMENT AND PREVENTION OF AUTOIMMUNE DISEASE
#6059FORMULATIONS AND METHODS FOR LYOPHILIZATION AND LYOPHILATES PROVIDED THEREBY
#6060Selection of patients for combination therapy
#6061BETA CATENIN NUCLEIC ACID INHIBITOR MOLECULE
#6062Method of treating IgG4-related disease
#6063TREATMENT OF ATOPIC DERMATITIS
#6064Anti-TNF antibodies, compositions, and methods for the treatment of active Ankylosing Spondylitis
#6065COMPOSITIONS AND METHODS FOR ANTI-LYST IMMUNOMODULATION
#6066OVEREXPRESSION OF FOXC1 TO TREAT CORNEAL VASCULARIZATION
#6067Method of managing joint pain
#6068Triptolide derivative and preparation method therefor and use thereof
#6069Tetrahydropyranooxazine derivatives having selective BACE1 inhibitory activity
#6070Treatment of infections and associated pathophysiological conditions
#6071METHODS FOR TREATING DISORDERS ASSOCIATED WITH ANGIOGENESIS AND NEOVASCULARIZATION
#6072Conjugate of methotrexate and peptide
#6073OCULAR APPLICATIONS OF SILK-BASED PRODUCTS
#6074Compositions and methods for treatment of neurological disorders
#6075Method for treating fibromyalgia and chronic fatigue syndrome
#6076TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
#6077Methods comprising continuous administration of exenatide and co-administration of a drug
#6078Stable liquid gonadotropin formulation
#6079METHODS FOR TREATING PEMPHIGUS DISORDERS
#6080Method of managing joint pain
#6081Formulations of vancomycin
#6082SUSTAINED ACTION FORMULATION OF CYCLOSPORIN FORM 2
#6083Reconstitutable teverelix-TFA composition
#6084Compositions and methods for treating nervous system injuries
#6085Method for treating cancer using dengue virus serotype 1 (DENV-1)
#6086METHODS FOR TREATING AND PREVENTING NOCICEPTIVE PAIN
#6087Treating Vitamin D insufficiency and deficiency with 25-hydroxyvitamin Dand 25-hydroxyvitamin D
#6088Methods of Treating Steroid Resistant Diseases and Conditions
#6089Method for treating coronavirus infections
#6090IMATINIB FOR USE IN THE TREATMENT OF STROKE
#6091Combination therapy for treatment of restenosis
#6092DANTROLENE FORMULATIONS AND METHODS OF THEIR USE
#6093COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#6094Formulation for pain management
#6095SYSTEM AND METHOD FOR ISOLATING EXTRACELLULAR VESICLES
#6096Composition and method for oral treatment of leukemia
#6097COMPOSITIONS AND METHODS FOR DELIVERY OF AAV
#6098Optimized host/vector system for producing protective mono- and multivalent subunit vaccines on the basis of the yeast
#6099Nucleic acid-drug complex and use thereof
#6100ANGIOGENESIS USING STIMULATED PLACENTAL STEM CELLS
#6101ANTI-TMPRSS2 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS
#6102DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#6103Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies
#6104METHODS FOR TREATING COPD BY ADMINISTERING AN IL-33 ANTAGONIST
#6105AMP-activated protein kinase activating compounds and uses thereof
#6106THIENO[2,3-B]PYRIDINE DERIVATIVES AS EPAC INHIBITORS AND THEIR PHARMACEUTICAL USES
#6107Fused ring compounds
#6108MUSCLE-TARGETING COMPLEXES AND USES THEREOF
#6109INTRAVENTRICULAR ENZYME DELIVERY FOR LYSOSOMAL STORAGE DISEASES
#6110OKRA-DERIVED ANTIVIRAL COMPOSITION AND USES THEREOF
#6111PHARMACEUTICAL COMPOSITION COMPRISING HYALURONIC ACID AND STEM CELLS FOR TREATING CARTILAGE DAMAGE-ASSOCIATED DISEASE
#6112Pharmaceutical composition comprising mesenchymal stem cells as effective ingredient for prevention or treatment of inflammatory disease
#6113LD Heparin for the treatment and secondary prevention of ischemic stroke
#6114Formulation for the use in the simultaneous treatment of coccidial infections and iron deficiencies
#6115Methods for treating pulmonary non-tuberculous mycobacterial infections
#6116ISOMORPHS OF REMDESIVIR AND METHODS FOR SYNTHESIS OF SAME
#6117Synergistic pharmaceutical composition comprising aceclofenac and betamethasone for the treatment of pain in localised forms of rheumatic illnesses
#6118SUBCUTANEOUSLY ADMINISTERED ANTI-IL-6 RECEPTOR ANTIBODY
#6119TREATING INFLUENZA USING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF
#6120Methods and Compositions for Maximizing the Prevention and/or Reduction of Various Maladies and Drug Side-Effects Using Uridine
#6121Methods and compositions for treating cancer
#6122Stabilizing Camptothecin Pharmaceutical Compositions
#6123Methods of treating RBP4 related diseases with triazolopyridines
#6124USE OF AMISULPRIDE AS AN ANTI-EMETIC
#6125SOLUBLE EPOXIDE HYDROLASE AS A TARGET FOR OCULAR DISEASES
#6126Utilization of cilastatin in inhibiting renal disorder
#6127INTRAVENOUS BACLOFEN FORMULATIONS AND TREATMENT METHODS
#6128METHODS FOR TREATING APOE4/4-ASSOCIATED DISORDERS
#6129Phenylephrine Hydrochloride Compositions and Containers
#6130Formulation and process for modulating wound healing
#6131METHODS OF PERMEABILIZING THE BLOOD BRAIN BARRIER
#6132Cationic materials and formulations for drug delivery
#6133HIGH CONCENTRATION HYDROGELS AND RELATED METHODS
#6134Inhibition of oxidation-specific epitopes to treat ischemic reperfusion injury
#6135Preparations and methods for treating a GD2 positive cancer
#6136COMBINATION OF BETA-ADRENERGIC RECEPTOR ANTAGONISTS AND CHECK POINT INHIBITORS FOR IMPROVED EFFICACY AGAINST CANCER
#6137Compositions and Methods Comprising an Anti-CD47 Antibody in Combination with a Tumor Targeting Antibody
#6138VSV/NDV HYBRID VIRUSES FOR ONCOLYTIC THERAPY OF CANCER
#6139CRYSTALLINE FORMS OF 1-(ACYLOXY)-ALKYL CARBAMATE DRUG CONJUGATES OF NAPROXEN AND PREGABALIN
#6140AMYGDALAR NEURAL ENSEMBLE THAT ENCODES THE UNPLEASANTNESS OF PAIN
#6141Long-acting polymeric delivery systems
#6142Methods for treating digitally identified IL-4/IL-13-related disorders by administering an anti-IL4R-alpha antibody
#6143NUCLEIC ACID VACCINES
#6144Vaccine Composition for Preventing or Treating Diseases Caused by Severe Fever with Thrombocytopenia Syndrome (SFTS) Viral Infection
#6145Development of dual whole cell-based vaccine against pancreatic cancer
#6146Use of bremelanotide in patients with controlled hypertension
#6147Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist
#6148Glycopeptide compositions
#6149Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells
#6150Compositions and methods for improving gastrointestinal function
#6151PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF MICRORNA RELATED DISEASES
#6152STABLE READY TO USE CYCLOPHOSPHAMIDE LIQUID FORMULATIONS
#6153COMPOSITIONS COMPRISING BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS AND METHODS OF USE THEREOF
#6154Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders
#6155Composition for reducing nervous system injury and method of making and use thereof
#6156Veterinary compositions and the uses thereof for controlling iron deficiencies in non-human mammals
#6157Flurbiprofen axetil emulsion for injection and preparation method thereof
#6158PEPTIDE/PARTICLE DELIVERY SYSTEMS
#6159Treatment method and product for uterine fibroids using purified collagenase
#6160Cationic lipids comprising a steroidal moiety
#6161Compositions and methods for controlled release of target agent
#6162TOPICAL INJECTABLE COMPOSITION
#6163Sustained Response Predictors After Treatment with Anti-IL23 Antibody
#6164Cytotoxic fluoropyrimidine polymers and methods of use thereof
#6165Adenoassociated virus vectors for the treatment of mucopolysaccharidoses type IV A
#6166DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) IN PEDIATRIC PATIENTS
#6167Rapaglutins, novel inhibitors of GLUT and use thereof
#6168N-aromatic amide compounds, preparation methods and uses thereof
#6169TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
#6170TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
#6171COMPOSITIONS AND METHODS FOR ACTIVATING CELLULAR SIGNALING PATHWAYS
#6172Compositions and methods for activating cellular signaling pathways
#6173COMPOSITIONS AND METHODS FOR ACTIVATING CELLULAR SIGNALING PATHWAYS
#6174TREATMENT OF BRAIN CANCER WITH ONCOLYTIC ADENOVIRUS
#6175Compositions and Methods for the Removal of Extraneous Calcium Hydroxyapatite
#6176Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
#6177Treatments of non-alcoholic steatohepatitis (NASH)
#6178Cobinamide compounds as a cyanide, sulfide, or methane-thiol antidote
#6179Antiviral prodrugs and nanoformulations thereof
#6180METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
#6181METHODS OF TREATING NEURODEGENERATIVE DISEASES USING INDANE ACETIC ACID DERIVATIVES WHICH PENETRATE THE BLOOD BRAIN BARRIER
#6182Biodegradable polymer microparticle containing steroid drug and preparation method therefor
#6183Membrane lipid coated nanoparticles and method of use
#6184Docetaxel palmitate liposome and preparation method thereof
#6185LEVODOPA INFUSION SOLUTION
#6186Aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yljcarbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea
#6187Aprepitant ready-to-use injection emulsion compositions
#6188METHODS AND COMPOSITIONS FOR INHIBITING A NOXIOUS INSULT
#6189THERAPEUTIC AND DIAGNOSTIC METHODS FOR BLADDER CANCER
#6190PROCESS TO REDUCE ENDOTOXIN IN GELATIN
#6191METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS
#6192METHODS AND COMPOSITIONS FOR DELIVERING MRNA CODED ANTIBODIES
#6193Methods for modulating an immune response
#6194Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
#61952-AZABICYCLO HEXANE JAK INHIBITOR COMPOUND
#6196PARATHYROID HORMONE AND REGENERATION OF DEGENERATIVE DISCS DISEASE
#6197Isolation of novel AAV's and uses thereof
#6198Compositions and methods for inhibiting the activity of LAR family phosphatases
#6199INJECTABLE THERMORESPONSIVE HYDROGELS AS A COMBINATORY MODALITY FOR CONTROLLED DRUG DELIVERY, BIOMATERIAL IMPLANT AND 3D PRINTING BIOINK
#6200Compositions of a polyorthoester and an organic acid excipient
#6201Targeted liposomes
#6202Methods for treatment of psoriasis with an anti-Apo B100 antibody
#6203Messenger RNA therapy for the treatment of ornithine transcarbamylase deficiency
#6204TERIPARATIDE-CONTAINING LIQUID PHARMACEUTICAL COMPOSITION HAVING EXCELLENT STABILITY
#6205PH 7 INJECTABLE SOLUTION COMPRISING AT LEAST ONE BASAL INSULIN OF WHICH THE PI IS FROM 5.8 TO 8.5 AND A CO-POLYAMINO ACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS AND A LIMITED AMOUNT OF M-CRESOL
#6206TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
#6207SELECTIVE TREG STIMULATOR RUR20kD-IL-2 AND RELATED COMPOSITIONS
#6208Use of a VEGF receptor-based fusion protein antagonist to treat nonproliferative diabetic retinopathy
#6209ECHO-7 ONCOLYTIC VIRUS FOR USE IN THE TREARMENT OF UVEAL MELANOMA
#6210Homogeneous engineered phage populations
#6211MITOCHONDRIAL AUGMENTATION THERAPY OF RENAL DISEASES
#6212Generating CIK NKT cells from cord blood
#6213METHODS AND COMPOSITIONS FOR THE TREATMENT OF OSTEOPETROSIS
#6214METHODS OF TREATING OSTEONECROSIS WITH LLP2A-BISPHOSPHONATE COMPOUNDS
#6215Agonists of stimulator of interferon genes sting
#6216Spirocyclic compounds as tryptophan hydroxylase inhibitors
#6217COMBINATION OF TOPOISOMERASE-I INHIBITORS WITH IMMUNOTHERAPY IN THE TREATMENT OF CANCER
#6218Ready-to-use tranexamic acid intravenous solution
#6219LIPOSOMAL ANTICANCER COMPOSITIONS
#6220Ready to use injectable formulations of melphalan and processes for preparation thereof
#6221METHODS FOR DETERMINING THE PRESENCE OR RISK OF DEVELOPING FACIOSCAPULOHUMERAL DYSTROPHY (FSHD)
#6222DELIVERING ENZYME USING AN INJECTABLE HYDROGEL DEPOT
#6223Peptidic TGF-beta antagonists
#6224Thioamide-modified peptides and uses thereof
#6225T-cell modulatory multimeric polypeptides and methods of use thereof
#6226INTEGRIN ANTAGONISTS
#6227Indanes as NRF2 activators
#6228OLIGONUCLEOTIDE CONSTRUCTS AND USES THEREOF
#6229GLYPISOME AS AN ENHANCER OF ANGIOGENIC GROWTH FACTOR ACTIVITY
#6230NANOPARTICLES WITH ENHANCED MUCOSAL PENETRATION OR DECREASED INFLAMMATION
#6231Liquid pharmaceutical composition
#6232TREATMENT OF TRIPLE NEGATIVE BREAST CANCER WITH TARGETED TGF-B INHIBITION
#6233Method to create personalized canine cancer vaccines
#6234Compositions and methods of interferon alpha binding proteins
#6235Compositions and Methods for Treating Steroid Hormone-Related Diseases or Disorders
#6236Ginkgo diterpene lactone composition
#6237COMPOSITIONS FOR CANCER THERAPY AND METHODS
#6238Methods to reduce complications of intra-articular steroid
#6239HYPOTENSIVE LIPID-CONTAINING BIODEGRADABLE INTRAOCULAR IMPLANTS AND RELATED METHODS
#6240BIARYL COMPOSITIONS AND METHODS FOR MODULATING A KINASE CASCADE
#6241Compositions and methods for treating eye disorders
#6242Aripiprazole sustained-release microsphere and preparation method therefor
#6243Method of preventing or improving UV-induced skin damage using hydroangenol as active ingredient
#6244COMPOSITIONS COMPRISING 3'-O-METHYL-4'-O-SULFATE EPICATECHIN AND THERAPEUTIC USES OF SUCH COMPOSITIONS
#6245TIGLIEN-3-ONE DERIVATIVES
#6246Beta-hydroxybutyrate mixed salt compositions and methods of use
#6247TREATMENT OF COVID-19
#6248NOVEL PARENTERAL CARBAMAZEPINE FORMULATION
#6249Replication competent adenoviral vectors
#6250Platform for generating safe cell therapeutics
#6251Method of manufacturing dual specific T-cells for use in cancer immunotherapy
#6252Compositions and methods for treating retinal diseases
#6253Medical device for administering anti-IL-23 antibodies
#6254Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes
#6255ONE-STEP, FAST, 18F-19F ISOTOPIC EXCHANGE RADIOLABELING OF DIFLUORO-DIOXABORININS AND USE OF SUCH COMPOUNDS IN TREATMENT
#6256Diazaspiro ROCK inhibitors
#6257Aza-indazole compounds for use in tendon and/or ligament injuries
#6258PERCUTANEOUSLY ADMINISTERED THERAPEUTIC SUBSTANCE FOR TREATMENT OF TARGET TISSUE
#6259Direct sodium removal method, solution and apparatus to reduce fluid overload in heart failure patients
#6260DECELLULARIZATION AND RECELLULARIZATION OF WHOLE ORGANS
#6261COMPOSITIONS AND METHODS FOR GENE EDITING FOR HEMOPHILIA A
#6262MESSENGER RNA THERAPY FOR THE TREATMENT OF FRIEDREICH'S ATAXIA
#6263Surfactants for use in healthcare products
#6264Vaccine compositions
#6265INJECTION TECHNIQUES FOR THE TREATMENT OF CELLULITE
#6266Modified factor VII polypeptides for subcutaneous administration and on-demand treatment
#6267Electrical stimulation of cells to induce enhanced secretome for therapeutic applications
#6268Treatment methods using botulinum toxins
#6269PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER
#6270Methods for treating hypotension in a patient that has received an ACE inhibitor by administering angiotensin II
#6271METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
#6272Glycan strands and oligosaccharides derived from bacteria
#6273FETAL TISSUE EXTRACT, METHODS FOR PRODUCING THE SAME, AND THE USES THEREOF
#6274COMPOUNDS THAT EXPAND HEMATOPOIETIC STEM CELLS
#6275PLASMA COMPOSITIONS AND METHODS OF USE THEREOF
#6276COMPOSITION AND METHOD FOR THE PREVENTION AND TREATMENT OF OBESITY
#6277METHOD OF TREATING NONALCOHOLIC STEATOHEPATITIS
#6278Composition and method for the treatment of type 2 diabetes
#6279Polymer lung surfactants
#6280Compositions and Devices for Systemic Delivery of Uridine
#6281Pharmaceutical compositions and uses thereof
#6282Ganaxolone for use in treatment of status epilepticus
#6283METHODS OF USE OF EMULSION FORMULATIONS OF APREPITANT
#6284MEDICAL USES
#6285Methods and compositions for treatment of Zika virus infection
#6286Cleavable conjugates of catechol compounds and water-soluble polymers and methods of treatment using the same
#6287Methods for compositions for reducing or eliminating symptoms of withdrawal from drugs and alcohol
#6288THERAPEUTIC FORMULATIONS AND USES THEREOF
#6289Sigma-1 receptor agonist systolic blood pressure therapy
#6290KETAMINE FORMULATION FOR SUBCUTANEOUS INJECTION
#6291NOVEL PENTOSAN POLYSULFATE SODIUM PREPARATION
#6292TARGETED DELIVERY OF HYDROPHILIC DRUGS TO LUNG
#6293Methods for production of MSC-derived exosomes
#6294MULTI-COMPONENT NANOCHAINS
#6295Sustained-release injectable composition comprising finasteride
#6296Dental Fracture Detection Compositions and Methods
#6297Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
#6298IN SITU GENE EDITING
#6299MODULATORS OF ENaC EXPRESSION
#6300Systems and methods for producing injectable enhanced stem cell exosomes, improved exosomes and methods of use